Comparison of Whole Blood RNA Preservation Tubes and Novel Generation RNA Extraction Kits for Analysis of mRNA and MiRNA Profiles

被引:50
作者
Haentzsch, Madlen [1 ,2 ]
Tolios, Alexander [3 ]
Beutner, Frank [1 ,2 ,4 ]
Nagel, Dorothea [3 ]
Thiery, Joachim [1 ,2 ]
Teupser, Daniel [1 ,3 ]
Holdt, Lesca M. [1 ,3 ]
机构
[1] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, D-04109 Leipzig, Germany
[2] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, Leipzig, Germany
[3] Univ Munich, Inst Lab Med, Munich, Germany
[4] Univ Leipzig, Ctr Heart, Dept Cardiol, D-04109 Leipzig, Germany
来源
PLOS ONE | 2014年 / 9卷 / 12期
关键词
ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; GENE-EXPRESSION; MATRIX-METALLOPROTEINASE-9; COLLECTION; STABILIZATION; TRANSCRIPTOME; SAMPLES; INJURY; SEQ;
D O I
10.1371/journal.pone.0113298
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Whole blood expression profiling is frequently performed using PAXgene (Qiagen) or Tempus (Life Technologies) tubes. Here, we compare 6 novel generation RNA isolation protocols with respect to RNA quantity, quality and recovery of mRNA and miRNA. Methods: 3 PAXgene and 3 Tempus Tubes were collected from participants of the LIFE study with (n=12) and without (n=35) acute myocardial infarction (AMI). RNA was extracted with 4 manual protocols from Qiagen (PAXgene Blood miRNA Kit), Life Technologies (MagMAX for Stabilized Blood Tubes RNA Isolation Kit), and Norgen Biotek (Norgen Preserved Blood RNA Purification Kit I and Kit II), and 2 (semi-) automated protocols on the QIAsymphony (Qiagen) and MagMAX Express-96 Magnetic Particle Processor (Life Technologies). RNA quantity and quality was determined. For biological validation, RNA from 12 representative probands, extracted with all 6 kits (n=72), was reverse transcribed and mRNAs (matrix metalloproteinase 9, arginase 1) and miRNAs (miR133a, miR1), shown to be altered by AMI, were analyzed. Results: RNA yields were highest using the Norgen Kit I with Tempus Tubes and lowest using the Norgen Kit II with PAXgene. The disease status was the second major determinant of RNA yields (LIFE-AMI 11.2 vs. LIFE 6.7 mu g, p < 0.001) followed by the choice of blood collection tube. (Semi-) automation reduced overall RNA extraction time but did not generally reduce hands-on-time. RNA yields and quality were comparable between manual and automated extraction protocols. mRNA expression was not affected by collection tubes and RNA extraction kits but by RT/qPCR reagents with exception of the Norgen Kit II, which led to mRNA depletion. For miRNAs, expression differences related to collection tubes (miR30b), RNA isolation (Norgen Kit II), and RT/qRT reagents (miR133a) were observed. Conclusion: We demonstrate that novel generation RNA isolation kits significantly differed with respect to RNA recovery and affected miRNA but not mRNA expression profiles.
引用
收藏
页数:17
相关论文
共 32 条
  • [1] Differential gene expression profiles are dependent upon method of peripheral blood collection and RNA isolation
    Asare, Adam L.
    Kolchinsky, Svetlana A.
    Gao, Zhong
    Wang, Richard
    Raddassi, Khadir
    Bourcier, Katarzyna
    Seyfert-Margolis, Vicki
    [J]. BMC GENOMICS, 2008, 9 (1)
  • [2] Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study
    Assimes, Themistocles L.
    Knowles, Joshua W.
    Basu, Analabha
    Iribarren, Carlos
    Southwick, Audrey
    Tang, Hua
    Absher, Devin
    Li, Jun
    Fair, Joan M.
    Rubin, Geoffrey D.
    Sidney, Stephen
    Fortmann, Stephen P.
    Go, Alan S.
    Hlatky, Mark A.
    Myers, Richard M.
    Risch, Neil
    Quertermous, Thomas
    [J]. HUMAN MOLECULAR GENETICS, 2008, 17 (15) : 2320 - 2328
  • [3] Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation
    Baechler, EC
    Batliwalla, FM
    Karypis, G
    Gaffney, PM
    Moser, K
    Ortmann, WA
    Espe, KJ
    Balasubramanian, S
    Hughes, KM
    Chan, JP
    Begovich, A
    Chang, SYP
    Gregersen, PK
    Behrens, TW
    [J]. GENES AND IMMUNITY, 2004, 5 (05) : 347 - 353
  • [4] Rationale and Design of the Leipzig (LIFE) Heart Study: Phenotyping and Cardiovascular Characteristics of Patients with Coronary Artery Disease
    Beutner, Frank
    Teupser, Daniel
    Gielen, Stephan
    Holdt, Lesca Miriam
    Scholz, Markus
    Boudriot, Enno
    Schuler, Gerhard
    Thiery, Joachim
    [J]. PLOS ONE, 2011, 6 (12):
  • [5] High-Resolution Transcriptome of Human Macrophages
    Beyer, Marc
    Mallmann, Michael R.
    Xue, Jia
    Staratschek-Jox, Andrea
    Vorholt, Daniela
    Krebs, Wolfgang
    Sommer, Daniel
    Sander, Jil
    Mertens, Christina
    Nino-Castro, Andrea
    Schmidt, Susanne V.
    Schultze, Joachim L.
    [J]. PLOS ONE, 2012, 7 (09):
  • [6] MiRNAs as Biomarkers of Myocardial Infarction: A MetaAnalysis
    Cheng, Chao
    Wang, Qiang
    You, Wenjie
    Chen, Manhua
    Xia, Jiahong
    [J]. PLOS ONE, 2014, 9 (02):
  • [7] A Panel of 4 microRNAs Facilitates the Prediction of Left Ventricular Contractility after Acute Myocardial Infarction
    Devaux, Yvan
    Vausort, Melanie
    McCann, Gerry P.
    Kelly, Dominic
    Collignon, Olivier
    Ng, Leong L.
    Wagner, Daniel R.
    Squire, Iain B.
    [J]. PLOS ONE, 2013, 8 (08):
  • [8] Human blood RNA stabilization in samples collected and transported for a large biobank
    Nur Duale
    Gunnar Brunborg
    Kjersti S Rønningen
    Thomas Briese
    Jeanette Aarem
    Kaja K Aas
    Per Magnus
    Camilla Stoltenberg
    Ezra Susser
    W Ian Lipkin
    [J]. BMC Research Notes, 5 (1)
  • [9] Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
    Ducharme, A
    Frantz, S
    Aikawa, M
    Rabkin, E
    Lindsey, M
    Rohde, LE
    Schoen, FJ
    Kelly, RA
    Werb, Z
    Libby, P
    Lee, RT
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (01) : 55 - 62
  • [10] Circulating Matrix Metalloproteinase-9 Is Associated with Cardiovascular Risk Factors in a Middle-Aged Normal Population
    Garvin, Peter
    Nilsson, Lennart
    Carstensen, John
    Jonasson, Lena
    Kristenson, Margareta
    [J]. PLOS ONE, 2008, 3 (03):